EUVIMEDEUVIMED entdecken
Crossref

Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis

Lin Wang, Ye Lu, Jiamei Liu, Siyi Wang, Zepeng Fei, Kaiwen Zhang, Dongfang Zhang, Xin Jin

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Lin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, China Medical University, No.77 of Puhe Road, Shenyang North New Area, Shenyang 110122, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Alzheimer Disease, Rats, Sprague-Dawley. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Current therapeutic agents for AD have limited efficacy and often induce undesirable side effects. Gegen Qinlian tablets (GGQLT) are a well-known clearingheat formula used in clinical treatment of inflammatory diseases. Based on traditional Chinese medicine (TCM) theory, the strategy of clearing-heat is then compatible with the treatment of AD. However, it remains unknown whether GGQLT can exert neuroprotective effects and alleviate neuroinflammation in AD. PURPOSE: This study aimed to evaluate the anti-AD effects of GGQLT and to decipher its intricate mechanism using integrative analyses of network pharmacology, transcriptomic RNA sequencing, and gut microbiota. METHODS: The ingredients of GGQLT were analyzed using HPLC-ESI-Q/TOF-MS. The AD model was established by bilateral injection of Aβ1-42 into the intracerebroventricular space of rats. The Morris water maze was used to evaluate the cognitive function of the AD rats. The long-term toxicity of GGQLT in rats was assessed by monitoring their body weights and pathological alterations in the liver and kidney. Reactive astrocytes and microglia were assessed by immunohistochemistry by labeling GFAP and Iba-1. The levels of inflammatory cytokines in the hippocampus were evaluated using ELISA kits, RT-PCR, and Western blot, respectively. The potential anti-AD mechanism was predicted by analyses of RNA-sequencing and network pharmacology. Western blot and immunohistochemistry were utilized to detect the phosphorylation levels of IκBα, NF-κB p65, p38, ERK and JNK. The richness and composition of gut bacterial and fungal microflora were investigated via 16S rRNA and ITS sequencing. RESULTS: Typical ingredients of GGQLT were identified using HPLC-ESI-Q/TOF-MS. GGQLT significantly improved the cognitive function of AD rats by suppressing the activation of microglia and astrocytes, improving glial morphology, and reducing the neuroinflammatory reactions in the hippocampus. RNA-sequencing, network and experimental pharmacological studies demonstrated that GGQLT inhibited the activation of NF-κB/MAPK signaling pathways in the hippocampus. GGQLT could also restore abnormal gut bacterial and fungal homeostasis and no longer-term toxicity of GGQLT was observed. CONCLUSIONS: Our findings, for the first time, demonstrate GGQLT exhibit anti-AD effects and is worthy of further exploration and development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDrugs, Chinese HerbalAlzheimer DiseaseRats, Sprague-DawleyDisease Models, AnimalNeuroinflammatory DiseasesAnimalsMaleRatsHippocampusNeuroprotective AgentsHomeostasisTabletsAmyloid beta-PeptidesNeurogliaNetwork PharmacologyDisease ProgressionCytokines

Stichwörter der Autor:innen

Alzheimer's diseasesGegen Qinlian tabletsGut microbiotaNF-κB/MAPK signaling pathwaysNeuroinflammation

Substanzen

Drugs, Chinese HerbalNeuroprotective AgentsTabletsAmyloid beta-PeptidesCytokines

Autor:innen und Institutionen

  • School of Pharmacy, China Medical University, No.77 of Puhe Road, Shenyang North New Area, Shenyang 110122, China.
  • Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
  • The 1st Clinical Department, China Medical University, Shenyang 110122, China.
  • School of Pharmacy, China Medical University, No.77 of Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: dfzhang@cmu.edu.cn.
  • School of Pharmacy, China Medical University, No.77 of Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: jinxin1117@163.com.

Förderung

  • Department of Science and Technology of Liaoning Province

Zitieren

APA

Wang, L., Lu, Y., Liu, J., Wang, S., Fei, Z., Zhang, K., Zhang, D., & Jin, X. (2024). Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155394

Vancouver

Wang L, Lu Y, Liu J, Wang S, Fei Z, Zhang K, et al. Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155394

BibTeX
@article{Wang2024,
  author = {Wang, Lin and Lu, Ye and Liu, Jiamei and Wang, Siyi and Fei, Zepeng and Zhang, Kaiwen and Zhang, Dongfang and Jin, Xin},
  title = {Gegen Qinlian tablets delay Alzheimer's disease progression via inhibiting glial neuroinflammation and remodeling gut microbiota homeostasis},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155394}
}
Kostenlos starten →